UBS Group
ENLV icon

UBS Group’s Enlivex Ltd ENLV Stock Holding History

UBS Group’s Portfolio ENLV Stock Details ENLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$129K Buy
9,222
+6,889
+295% +$109K ﹤0.01% 6877
2025
Q4 		$24.6K Buy
2,333
+2,064
+767% +$30.8K ﹤0.01% 7648
2025
Q3 		$4.2K Buy
+269
New +$4.85K ﹤0.01% 8965
2025
Q2 		– Sell
-1
Closed -$16 – 10388
2025
Q1 		$16 Hold
1
– – ﹤0.01% 10102
2024
Q4 		$19 Sell
1
-213
-100% -$4.14K ﹤0.01% 9777
2024
Q3 		$5.41K Buy
214
+213
+21,300% +$4.33K ﹤0.01% 8058
2024
Q2 		$23 Sell
1
-204
-100% -$5.42K ﹤0.01% 9300
2024
Q1 		$11.6K Sell
205
-39
-16% -$1.91K ﹤0.01% 7171
2023
Q4 		$9.89K Buy
244
+198
+430% +$5.04K ﹤0.01% 7465
2023
Q3 		$1.09K Sell
46
-1,141
-96% -$39.5K ﹤0.01% 8111
2023
Q2 		$46.8K Sell
1,187
-910
-43% -$38K ﹤0.01% 6514
2023
Q1 		$114K Sell
2,097
-133
-6% -$8.02K ﹤0.01% 5810
2022
Q4 		$132K Buy
2,230
+105
+5% +$6.78K ﹤0.01% 5837
2022
Q3 		$136K Buy
2,125
+900
+73% +$65.8K ﹤0.01% 5434
2022
Q2 		$83K Buy
1,225
+46
+4% +$3.56K ﹤0.01% 5558
2022
Q1 		$99K Sell
1,179
-264
-18% -$21.4K ﹤0.01% 5923
2021
Q4 		$135K Buy
1,443
+413
+40% +$48.6K ﹤0.01% 6021
2021
Q3 		$152K Buy
1,030
+135
+15% +$19.8K ﹤0.01% 5532
2021
Q2 		$120K Buy
895
+170
+23% +$25.6K ﹤0.01% 5742
2021
Q1 		$120K Sell
725
-768
-51% -$158K ﹤0.01% 5824
2020
Q4 		$189K Buy
1,493
+811
+119% +$130K ﹤0.01% 5270
2020
Q3 		$61K Buy
682
+659
+2,865% +$51.8K ﹤0.01% 5497
2020
Q2 		$2K Buy
+23
New +$1.84K ﹤0.01% 7623
2020
Q1 		– Sell
-192
Closed -$24K – 8060
2019
Q4 		$24K Sell
192
-20
-9% -$2.64K ﹤0.01% 6769
2019
Q3 		$85K Buy
212
+109
+106% +$43.8K ﹤0.01% 5856
2019
Q2 		$33K Buy
+103
New +$19K ﹤0.01% 6252
2019
Q1 		– Sell
-41
Closed -$4K – 7814
2018
Q4 		$4K Buy
+41
New +$6.29K ﹤0.01% 7624
2018
Q3 		– Sell
-19
Closed -$4K – 8043
2018
Q2 		$4K Hold
19
– – ﹤0.01% 7539
2018
Q1 		$5K Hold
19
– – ﹤0.01% 7224
2017
Q4 		$5K Buy
+19
New +$5.07K ﹤0.01% 7370
2017
Q3 		– Sell
-10
Closed -$4K – 7784
2017
Q2 		$4K Sell
10
-5
-33% -$1.52K ﹤0.01% 7201
2017
Q1 		$7K Buy
15
+8
+114% +$5.27K ﹤0.01% 6809
2016
Q4 		$4K Sell
7
-2
-22% -$1.69K ﹤0.01% 7319
2016
Q3 		$10K Buy
+9
New +$9.14K ﹤0.01% 6776
2016
Q2 		– Sell
-3
Closed -$4K – 7789
2016
Q1 		$4K Sell
3
-9
-75% -$16K ﹤0.01% 7080
2015
Q4 		$27K Buy
+12
New +$33.8K ﹤0.01% 6429
2015
Q3 		– Sell
-6
Closed -$24K – 8462
2015
Q2 		$24K Buy
+6
New +$22.3K ﹤0.01% 6701

Other funds holding ENLV

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's ENLV Position: Q1 2026 in Review

UBS Group increased its Enlivex Ltd (ENLV) stake by 295% in Q1 2026, buying an estimated $109K and bringing the position to 9,222 shares worth $129K. The position accounts for ﹤0.01% of the portfolio, ranked #6877.

UBS Group first reported a position in ENLV in Q2 2015 and has held it in 37 quarters since. The position peaked at $189K in Q4 2020. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

  • UBS Group held 9,222 shares of Enlivex Ltd worth $129K as of Q1 2026.
  • UBS Group bought 6,889 Enlivex Ltd shares in Q1 2026, an estimated $109K.
  • Enlivex Ltd made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6877 holding.
  • UBS Group first reported a position in Enlivex Ltd in Q2 2015 and has held it in 37 quarters since.
  • UBS Group's Enlivex Ltd position peaked at $189K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.